Slate Path Capital LP

13F Holdings History for Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Symbol: CYCN on Nasdaq
Investment type: Equity / Common Stock, no par value
Latest Disclosed Ownership: 0 shares
Security Ownership: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Slate Path Capital LP ownership in Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)

2024-12-06 - Slate Path Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN). This represents 0% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Slate Path Capital LP	0%			0			$2.56	13G/A	11/30/2024	6 Dec 2024 16:05:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		-0.02%	$0	0	-357,880	-100%		Q4 2024
9/30/2024	0.02%		$927K	358K			$2.59	Q3 2024
6/30/2024	0.02%		$823K	358K			$2.30	Q2 2024
3/31/2024	0.02%		$1.15M	358K			$3.20	Q1 2024
12/31/2023	0.03%		$1.2M	358K			$3.35	Q4 2023
9/30/2023	0.03%		$1.22M	358K			$3.42	Q3 2023
6/30/2023	0.05%	+0.05%	$1.47M	358K	+357,880	NEW	$4.12	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.